Shuttle Pharmaceuticals (SHPH) Insider Trading & Ownership $3.60 +0.15 (+4.35%) Closing price 04:00 PM EasternExtended Trading$3.52 -0.08 (-2.22%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Shuttle Pharmaceuticals (NASDAQ:SHPH) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage12.60%Number OfInsiders Buying(Last 3 Years)0Number OfInsiders Selling(Last 3 Years)3Amount OfInsider Selling(Last 3 Years)$11.55K Get SHPH Insider Trade Alerts Want to know when executives and insiders are buying or selling Shuttle Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address SHPH Insider Buying and Selling by Quarter Shuttle Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/13/2023Bette JacobsDirectorSell166$11.50$1,909.00 12/29/2022Hoek Michael VanderCFOSell89$40.00$3,560.00 12/29/2022Peter DritschiloCOOSell152$40.00$6,080.00 (Data available from 1/1/2013 forward) SHPH Insider Trading Activity - Frequently Asked Questions Who is on Shuttle Pharmaceuticals' Insider Roster? The list of insiders at Shuttle Pharmaceuticals includes Bette Jacobs, Hoek Michael Vander, and Peter Dritschilo. Learn more on insiders at SHPH. What percentage of Shuttle Pharmaceuticals stock is owned by insiders? 12.60% of Shuttle Pharmaceuticals stock is owned by insiders. Learn more on SHPH's insider holdings. Which Shuttle Pharmaceuticals insiders have been selling company stock? The following insider sold SHPH shares in the last 24 months: Bette Jacobs ($1,909.00). How much insider selling is happening at Shuttle Pharmaceuticals? Insiders have sold a total of 166 Shuttle Pharmaceuticals shares in the last 24 months for a total of $1,909.00 sold. Shuttle Pharmaceuticals Key ExecutivesDr. Anatoly Dritschilo M.D. (Age 80)Co-Founder, CEO & Chairman of the Board Compensation: $399.18kMr. Peter Dale Dritschilo M.B.A. (Age 55)M.D., President & COO Compensation: $314.01kDr. Milton Brown CSC (Age 59)M.D., Ph.D., Co-Founder & Director Mr. Michael P. Vander Hoek (Age 64)CFO and VP of Operations & Regulatory Compensation: $302.53kDr. Tyvin A. Rich M.D. (Age 76)Chief Clinical Officer & Chief Medical Officer Compensation: $263.23kDr. Mira Jung Ph.D. (Age 75)Co-Founder & Chief Scientific Officer for Biology Mr. Gene Jung Esq.General Counsel More Insider Trading Tools from MarketBeat Related Companies Moleculin Biotech Insider Transactions Biomerica Insider Transactions IN8bio Insider Transactions Genprex Insider Transactions Sensei Biotherapeutics Insider Transactions Acurx Pharmaceuticals Insider Transactions Turnstone Biologics Insider Transactions Chromocell Therapeutics Insider Transactions Cardio Diagnostics Insider Transactions HCW Biologics Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Summer Stocks With Insider Buying and Analyst Support3 Tightly-Held Growth Stocks Set Up for Short SqueezesTankers, Takedowns & Air Taxis: Insiders Are Buying These 3 Names3 Tech Stocks Insiders Are Buying: Speculative Plays for JuneDividend Investors Looking for an Edge? 3 Stocks Insiders Bought This page (NASDAQ:SHPH) was last updated on 6/18/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMost Bitcoin holders have no idea this existsHere’s what 99% of Bitcoin holders don’t know: There’s a way to amplify your Bitcoin gains without buying m...Brownstone Research | SponsoredElon’s End Game Is Going Live -- And It Could Make You a FortuneThe media and the so-called experts have laughed at Elon Musk his entire career. CBS called PayPal “one of ...The Oxford Club | SponsoredSorry about the swear wordWhat a huge few months for Bitcoin. First, Bitcoin hit $100,000… Then, Donald Trump pledged to create an...Manward Press | SponsoredGold Just Jumped Again. Here’s How to Get PaidGold prices just spiked again. As I write this, gold is trading near $3,400 an ounce. But here's the thi...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shuttle Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Shuttle Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.